Quality and Safety
Trials with non-industry sponsors are far more likely to breach the rules than trials sponsored by industry.
Justin Gernot, vice president of HIMSS subsidiary Healthbox, says to find success in innovation, health organizations must avoid a number of pitfalls.
Tohoku University's Dr. Masaharu Nakayama details how his group withstood the disruption of Japan's 2011 earthquake, and why that level of resilience is difficult to maintain.
The findings support the notion that the readmission policy is safe and not increasing the risk of death by turning away patients.
There are challenges separating effective innovations from the chaff, says Dennis Robbins, a member of the AHA's Health Tech Advisory Group.
Every year, an estimated 1.3 million U.S. adults with heart disease may qualify for cardiac rehabilitation.
Maureen Baker, chair of the Professional Records Standards Body, discusses the PRSB's collaboration with providers of health and social care in the UK and abroad.
The bureaucratic demands of medical practice topped the list of reasons for burnout for all generations, followed by long hours.
AHA President Dr. Robert Harrington discusses why cardiology is primed for the adoption of data-driven innovations.
The cost of ownership and repair of medical equipment, from infusion pumps to MRI machines, can be quite burdensome for the healthcare industry.